Research progress in molecular pathology markers in medulloblastoma
Medulloblastoma (MB) is the commonest primary malignant brain cancer. The current treatment of MB is usually surgical resection combined with radiotherapy or chemotherapy. Although great progress has been made in the clinical management of MB, tumor metastasis and recurrence are still the main cause...
Saved in:
Main Authors: | Zixuan Zhou (Author), Bingxin Zhu (Author), Qingming Meng (Author), Tong Zhang (Author), Yihao Wu (Author), Rutong Yu (Author), Shangfeng Gao (Author) |
---|---|
Format: | Book |
Published: |
Open Exploration Publishing Inc.,
2023-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Molecular Biology of Medulloblastoma
by: J Gordon Millichap
Published: (2007) -
Molecular variants and mutations in medulloblastoma
by: Schroeder K, et al.
Published: (2014) -
Review of the impact of molecular analysis on the therapy of medulloblastoma
by: Supriya Sarvode, et al.
Published: (2023) -
Overview of molecular subtype of medulloblastoma and role of MRI in their identification
by: Ashfaq Ahmad, et al.
Published: (2022) -
Medulloblastoma
by: Indu Rekha Meesa
Published: (2019)